Coronavirus treatment: Gilead's remdesivir combination research - Business Insider

The key will be crafting the right cocktail of medications, testing additional drugs in combination with the antiviral remdesivir, COVID-19 researchers told Business Insider.

Remdesivir's use should help free up hospital beds, intensive care units, and ventilators as patients recover faster on the drug. But the real advantage will be its potential to serve as a backbone in combination studies, Gold said. "Those are critical trials, and I think will be coming in the relatively near term," said Badley, who chairs Mayo's COVID-19 research task force.Remdesivir will be tested in combination with an arthritis drug

Bell said he is most excited about combination trials where each of the drugs can treat distinct phases of the disease.

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว

Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้

Coronavirus treatment: Gilead says positive data on remdesivir coming - Business InsiderOne of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID-19 patients, Gilead said Wednesday.
แหล่ง: BusinessInsider - 🏆 729. / 51 อ่านเพิ่มเติม »

Stocks jump as investors weigh Gilead coronavirus treatment, GDP dataU.S. stocks rebounded Wednesday as upbeat data on coronavirus treatment from Gilead Sciences offset fresh figures that showed U.S. economic growth contracted more than expected in the first quarter. Upbeat data? 🤔🤔🤔 Fake Stock Market
แหล่ง: USATODAY - 🏆 100. / 63 อ่านเพิ่มเติม »